|
|
|
40
|
B4811
|
VYMADA 24MG | 26MG TAB (NVS/COL) SACUBITRIL | VALSARTAN
|
SACUBITRIL|VALSARTAN
|
VYMADA
|
28'S
|
B
|
70.68
|
2.52
|
TABLET
|
0
|
TAB
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
|
243208
|
ANGIOTENSIN II RECEPTOR ANTAGONIST
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CARDIOVASCULAR DRUGS
|
|
|
|
|
41
|
B4811
|
VYMADA 24MG|26MG TAB (NVS) SACUBITRIL|VALSARTAN (B)
|
SACUBITRIL|VALSARTAN
|
VYMADA
|
28'S
|
B
|
65.24
|
2.33
|
TAB
|
60
|
BOX
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
|
243208
|
ANGIOTENSIN II RECEPTOR ANTAGONIST
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ANGIOTENSIN II RECEPTOR ANTAGONIST
|
|
|
|
|
42
|
B4811
|
VYMADA 24MG|26MG TAB (NVS) SACUBITRIL|VALSARTAN
|
SACUBITRIL|VALSARTAN
|
VYMADA
|
28'S
|
B
|
48.93
|
1.75
|
TAB
|
60
|
BLIS
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
AVENTA BARBADOS
|
|
243208
|
ANGIOTENSIN II RECEPTOR ANTAGONIST
|
2026-04-01
|
|
|
ORAL
|
6
|
ANGIOTENSIN II RECEPTOR ANTAGONIST
|
|
|
|
|
40
|
B4812
|
VYMADA 49MG | 51MG TAB (NVS/COL) SACUBITRIL | VALSARTAN
|
SACUBITRIL|VALSARTAN
|
VYMADA
|
28'S
|
B
|
70.68
|
2.52
|
TABLET
|
0
|
TAB
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
|
243208
|
ANGIOTENSIN II RECEPTOR ANTAGONIST
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CARDIOVASCULAR DRUGS
|
|
|
|
|
41
|
B4812
|
VYMADA 49MG|51MG TAB (NVS) SACUBITRIL|VALSARTAN (B)
|
SACUBITRIL|VALSARTAN
|
VYMADA
|
28'S
|
B
|
65.24
|
2.33
|
TAB
|
60
|
BOX
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
|
243208
|
ANGIOTENSIN II RECEPTOR ANTAGONIST
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ANGIOTENSIN II RECEPTOR ANTAGONIST
|
|
|
|
|
42
|
B4812
|
VYMADA 49MG|51MG TAB (NVS) SACUBITRIL|VALSARTAN
|
SACUBITRIL|VALSARTAN
|
VYMADA
|
28'S
|
B
|
48.93
|
1.75
|
TAB
|
60
|
BLIS
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
AVENTA BARBADOS
|
|
243208
|
ANGIOTENSIN II RECEPTOR ANTAGONIST
|
2026-04-01
|
|
|
ORAL
|
6
|
ANGIOTENSIN II RECEPTOR ANTAGONIST
|
|
|
|
|
40
|
B4813
|
VYMADA 97MG | 103MG TAB (NVS/COL) SACUBITRIL | VALSARTAN
|
SACUBITRIL|VALSARTAN
|
VYMADA
|
28'S
|
B
|
70.68
|
2.52
|
TABLET
|
0
|
TAB
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
|
243208
|
ANGIOTENSIN II RECEPTOR ANTAGONIST
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CARDIOVASCULAR DRUGS
|
|
|
|
|
41
|
B4813
|
VYMADA 97MG|103MG TAB (NVS) SACUBITRIL|VALSARTAN (B)
|
SACUBITRIL|VALSARTAN
|
VYMADA
|
28'S
|
B
|
65.24
|
2.33
|
TAB
|
60
|
BOX
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
|
243208
|
ANGIOTENSIN II RECEPTOR ANTAGONIST
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ANGIOTENSIN II RECEPTOR ANTAGONIST
|
|
|
|
|
42
|
B4813
|
VYMADA 97MG|103MG TAB (NVS) SACUBITRIL|VALSARTAN
|
SACUBITRIL|VALSARTAN
|
VYMADA
|
28'S
|
B
|
48.93
|
1.75
|
TAB
|
60
|
BLIS
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
AVENTA BARBADOS
|
|
243208
|
ANGIOTENSIN II RECEPTOR ANTAGONIST
|
2026-04-01
|
|
|
ORAL
|
6
|
ANGIOTENSIN II RECEPTOR ANTAGONIST
|
|